Claudication, Intermittent
19
5
6
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (19)
Red Light Treatment in Peripheral Artery Disease
The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia
Passive Calf Stretching Therapy in Peripheral Artery Disease
The SIR-POBA Bypass Trial
Exercise Training Study of Patients With Claudicatio Intermittens
Exercise Tolerance After Venous Recanalization for Post-thrombotic Syndrome
Additional Hyperbaric Oxygen After Lower Extremity Amputation
REmotely Supervised Exercise Therapy Trial 2
FRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial
Pedal Acceleration Time (PAT) as a Measure of Foot Perfusion
Mobile Intervention Supervised Exercise Therapy Study 1
Evaluation of Safety and Effectiveness of Lobster Dynamic Interspinous Spacer in Lumbar Spinal Stenosis
Lactate Increase in Peripheral Artery Disease
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
Safety and Efficacy of Atherectomy on VasculaR Functions
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
Platelet Reactivity in PAD Undergoing Percutaneous Angioplasty
SFA TReatment and vAscular Functions